Wells Fargo’s Mustang Bio MBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-400
| Closed | -$500 | – | 7282 |
|
|
2025
Q1 | $500 | Hold |
400
| – | – | ﹤0.01% | 6269 |
|
|
2024
Q4 | $3.54K | Buy |
400
+220
| +122% | +$2.43K | ﹤0.01% | 6114 |
|
|
2024
Q3 | $2.12K | Buy |
180
+120
| +200% | +$1.98K | ﹤0.01% | 6048 |
|
|
2024
Q2 | $1.42K | Buy |
60
+57
| +1,900% | +$1.08K | ﹤0.01% | 6063 |
|
|
2024
Q1 | $159 | Hold |
3
| – | – | ﹤0.01% | 6553 |
|
|
2023
Q4 | $203 | Hold |
3
| – | – | ﹤0.01% | 6608 |
|
|
2023
Q3 | $292 | Hold |
3
| – | – | ﹤0.01% | 6488 |
|
|
2023
Q2 | $882 | Hold |
3
| – | – | ﹤0.01% | 6344 |
|
|
2023
Q1 | $765 | Hold |
3
| – | – | ﹤0.01% | 6448 |
|
|
2022
Q4 | $818 | Hold |
3
| – | – | ﹤0.01% | 6244 |
|
|
2022
Q3 | $1K | Sell |
3
-18
| -86% | -$8.34K | ﹤0.01% | 6390 |
|
|
2022
Q2 | $9K | Buy |
21
+1
| +5% | +$554 | ﹤0.01% | 5796 |
|
|
2022
Q1 | $16K | Sell |
20
-34
| -63% | -$27.9K | ﹤0.01% | 6101 |
|
|
2021
Q4 | $68K | Buy |
54
+21
| +64% | +$33.9K | ﹤0.01% | 5826 |
|
|
2021
Q3 | $66K | Buy |
33
+8
| +32% | +$17.2K | ﹤0.01% | 5530 |
|
|
2021
Q2 | $61K | Sell |
25
-15
| -38% | -$36.8K | ﹤0.01% | 5478 |
|
|
2021
Q1 | $99K | Sell |
40
-78
| -66% | -$232K | ﹤0.01% | 5494 |
|
|
2020
Q4 | $335K | Buy |
118
+74
| +168% | +$177K | ﹤0.01% | 4806 |
|
|
2020
Q3 | $103K | Sell |
44
-13
| -23% | -$32K | ﹤0.01% | 5253 |
|
|
2020
Q2 | $136K | Buy |
57
+10
| +21% | +$23.4K | ﹤0.01% | 5083 |
|
|
2020
Q1 | $94K | Sell |
47
-1
| -2% | -$2.56K | ﹤0.01% | 5094 |
|
|
2019
Q4 | $147K | Hold |
48
| – | – | ﹤0.01% | 5127 |
|
|
2019
Q3 | $118K | Buy |
48
+37
| +336% | +$101K | ﹤0.01% | 5242 |
|
|
2019
Q2 | $31K | Buy |
11
+1
| +10% | +$2.85K | ﹤0.01% | 5689 |
|
|
2019
Q1 | $26K | Sell |
10
-1
| -9% | -$2.83K | ﹤0.01% | 5466 |
|
|
2018
Q4 | $25K | Sell |
11
-13
| -54% | -$39.5K | ﹤0.01% | 5718 |
|
|
2018
Q3 | $108K | Hold |
24
| – | – | ﹤0.01% | 5327 |
|
|
2018
Q2 | $125K | Buy |
24
+7
| +41% | +$44.2K | ﹤0.01% | 5277 |
|
|
2018
Q1 | $144K | Sell |
17
-1
| -6% | -$8.52K | ﹤0.01% | 5150 |
|
|
2017
Q4 | $164K | Buy |
+18
| New | +$139K | ﹤0.01% | 5060 |
|
Other funds holding MBIO
TRCT
SS
HI
Wells Fargo's MBIO Position: Q2 2025 in Review
Wells Fargo sold out of Mustang Bio (MBIO) in Q2 2025, closing a stake of 400 shares — an estimated $500 sold.
Wells Fargo first reported a position in MBIO in Q4 2017 and held it in 30 quarters. The position peaked at $335K in Q4 2020. 17 funds tracked by Wall St. Rank hold MBIO as of Q2 2025.
- Wells Fargo reported no remaining Mustang Bio position as of Q2 2025 after selling out during the quarter.
- Wells Fargo sold 400 Mustang Bio shares in Q2 2025, an estimated $500.
- Wells Fargo first reported a position in Mustang Bio in Q4 2017 and held it in 30 quarters.
- Wells Fargo's Mustang Bio position peaked at $335K in Q4 2020.
- 17 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2025.
Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.